ArticleFrontiers in oncology2022

Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER-based study.

Donglin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.